Bilateral catheter-directed thrombolysis in a patient with deep venous thrombosis caused by a hypoplastic inferior vena cava

Phlebology. 2015 May;30(4):293-5. doi: 10.1177/0268355514524194. Epub 2014 Feb 13.

Abstract

Introduction: Deep venous thrombosis treatment using catheter-directed thrombolysis is advocated over systemic thrombolysis because it reduces bleeding complications. With the development of a catheter that combines ultrasound vibrations and the local delivering of thrombolytics, new and safer treatments appear that are suitable for more complex problems.

Report: An adolescent male presented with bilateral iliofemoral thrombosis based on a hypoplastic inferior vena cava that had existed for more than two weeks. He was successfully treated by bilateral ultrasound-accelerated catheter-directed thrombolysis using EkoSonic® (Small Vessel) Endovascular System (EKOS) and stenting of the inferior vena cava. After eight months of follow-up, the inferior vena cava is still patent.

Conclusion: EKOS thrombolysis of longer existing bilateral deep venous thrombosis in the central venous system is a successful treatment modality in congenital inferior vena cava anomalies.

Keywords: Deep venous thrombosis; EKOS; inferior vena cava anomalies; post-thrombotic stress syndrome; ultra-sound catheter-directed thrombolysis.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Combined Modality Therapy
  • Femoral Vein / diagnostic imaging
  • Hepatomegaly / etiology
  • Humans
  • Hypertension, Portal / etiology
  • Iliac Vein / diagnostic imaging
  • Intermittent Pneumatic Compression Devices
  • Male
  • Mechanical Thrombolysis / instrumentation
  • Mechanical Thrombolysis / methods*
  • Pain Management
  • Phlebography
  • Splenomegaly / etiology
  • Thrombolytic Therapy
  • Ultrasonography, Interventional
  • Urokinase-Type Plasminogen Activator / therapeutic use
  • Vascular Patency
  • Vena Cava, Inferior / abnormalities*
  • Vena Cava, Inferior / diagnostic imaging
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / therapy*
  • Young Adult

Substances

  • Anticoagulants
  • Urokinase-Type Plasminogen Activator